On November 1, 2023, revised USP Chapters 795 and 797 are official. If adopted by your state board of pharmacy, the requirements listed within these Chapters must be met. All PCCA formulations in our formula database now contain updated language and beyond-use dates (BUDs) in compliance with USP Chapters 795 and 797.

Functional medicine, a biology-based approach that focuses on identifying and addressing the root cause of diseases, is a popular topic. And so is healthy aging. It’s no wonder, especially when we consider our desire to understand the root cause of diseases and sustain health throughout life’s many stages.

This Profile in Personalized Medicine highlights Doug Smith, Pharmacy Technician. He is a co-owner of Smith Rexall Compounding Pharmacy in Pleasant Grove, Utah, and Smith Rexall Compounding Pharmacy in Lehi, Utah. The Smith Rexall Compounding Pharmacies have been a proud PCCA member since 1999.

Due to pending USP updates that are effective on November 1, 2023, we’re reposting our January Blog, which reviews how a modular compounding cleanroom can meet evolving regulatory requirements and standards.

Get a glimpse of how you and your pharmacy can achieve growth and success in this prelude to International Seminar 2023.

Read how estrogen levels in men impact testosterone levels, the consequences of low testosterone and the potential ways compounding pharmacies can help.

This Profiles in Personalized Medicine highlights Steve Branch, RPh, and Cherise Kutac Branch, APRN, FNP-BC, FAAMM, owners of Central Drug Compounding & Wellness in Victoria, Texas. They have been proud PCCA members since 1988. Our 2023 profiles ask pharmacy compounders how they incorporate PCCA’s Principles into their pharmacies.

PCCA Clinical Compounding Pharmacist Deborah H. Clark examines the clinical presentations and available medications for feline atopic skin syndrome (FASS).

Multiple studies indicate some patients with COVID-19 infection may develop vertigo. Read how betahistine helped relieve symptoms of vertigo in these post-COVID patients.

Review the criteria for selecting an FDA-approved API to safeguard your patients and your compounding pharmacy.